Does inhibition of L-type amino acid transporter 1 have antitumor activity in non-small cell lung cancer?
Inhibition of LAT1 may be a new rationale to the effective therapy of NSCLC without EGFR mutation.
The perceived functional impact of fatigue on quality of life is significantly higher in patients with chronic HCV genotype 1b infection compared to healthy controls. However, it is unrelated to the degree of hepatitis and cannot be accounted for by the co-existence of autoimmune disorders alone.